Verbruggen, L. C., Wang, Y., Armenian, S. H., Ehrhardt, M. J., van der Pal, H. J., van Dalen, E. C., van As, J. W., Bardi, E., Baust, K., Berger, C., Castagnola, E., Devine, K. A., Gebauer, J., Marchak, J. G., Glaser, A. W., Groll, A. H., Haeusler, G. M., den Hartogh, J., Haupt, R., Hjorth, L., Kato, M., Kepák, T., Koopman, M. M. (., Langer, T., Maeda, M., Michel, G., Muraca, M., Nathan, P. C., van den Oever, S. R., Pavasovic, V., Sato, S., Schulte, F., Sung, L., Tissing, W., Uyttebroeck, A., Mulder, R. L., Kuehni, C., Skinner, R., Hudson, M. M., & Kremer, L. C. (2020). guidance regarding COVID‐19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatric blood & cancer, 67(12), n/a. http://access.bl.uk/ark:/81055/vdc_100113085548.0x000006